Assignee
EPIMMUNE INC
US·13 granted patents·5 pending applications·1,007 citations·filing 1993–2015
Top patents by PatentIndex Score
18 records- 0197US6037135AMethods for making HLA binding peptides and their usesEPIMMUNE INC·Filed 1993·Granted Mar 14, 2000·308 cites·68 claims
- 0296US7026443B1Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2000·Granted Apr 11, 2006·92 cites·10 claims
- 0396US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0494US6534482B1Expression vectors for stimulating an immune response and methods of using the sameEPIMMUNE INC·Filed 1999·Granted Mar 18, 2003·155 cites·4 claims
- 0592US7888472B2Optimized multi-epitope constructs and uses thereofEPIMMUNE INC·Filed 2009·Granted Feb 15, 2011·12 cites·6 claims
- 0690US6419931B1Compositions and methods for eliciting CTL immunityEPIMMUNE INC·Filed 1994·Granted Jul 16, 2002·94 cites·27 claims
- 0788US6413935B1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 1997·Granted Jul 2, 2002·73 cites·52 claims
- 0884US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 0979US6413517B1Identification of broadly reactive DR restricted epitopesEPIMMUNE INC·Filed 1998·Granted Jul 2, 2002·40 cites·2 claims
- 1076US6464980B1MAGE-1 c-terminal immunogenic peptidesEPIMMUNE INC·Filed 1996·Granted Oct 15, 2002·23 cites·5 claims
- 1172US6322789B1HLA-restricted hepatitis B virus CTL epitopesEPIMMUNE INC·Filed 1995·Granted Nov 27, 2001·44 cites·22 claims
- 1271US8017745B2Plasmodium falciparum antigens and methods of useEPIMMUNE INC·Filed 2003·Granted Sep 13, 2011·3 cites·38 claims
- 1358US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1455US9789181B2PAN-DR binding polypeptides and uses thereofEPIMMUNE INC·Filed 2015·Granted Oct 17, 2017·0 cites·12 claims
- 1555US2004157780A1CTL inducing peptides from c-erb2 (HER-2/neu)EPIMMUNE INC·Filed 2004·Application pending·0 cites
- 1654US2005049197A1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 2004·Application pending·0 cites
- 1749US2005271676A1Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1848US2016193316A1Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid CompositionsEPIMMUNE INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →